|Bid||9.80 x 800|
|Ask||10.34 x 1400|
|Day's Range||9.90 - 10.20|
|52 Week Range||1.87 - 11.07|
|Beta (5Y Monthly)||1.11|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.00|
AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced that it filed today with the Australian Securities Exchange (ASX) its Appendix 4D – Half-Year Report for the six month period ended 31 December 2019.
AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a global regenerative medicine company, announced that management will present at the Cowen 40th Annual Health Care Conference in Boston. The presentation is being made on 4 March 2020 from 9:20 a.m. to 9:50 a.m. EST at the Boston Marriott Copley Place hotel. Interested parties may access a webcast of the presentation on the "Investors" section of the company’s website at: https://www.avitamedical.com/investors.
We think all investors should try to buy and hold high quality multi-year winners. And we've seen some truly amazing...
AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, reported financial results for the fiscal second quarter ended 31 December 2019 today in its Appendix 4C - Quarterly Cash Flow Report filed with the Australian Securities Exchange (ASX).
After-hours price action in Avita Medical Ltd. ADR (NASDAQ: RCEL ), a blockbuster earnings report and a significant ratings change were a few of the topics on today's PreMarket Prep Show . Buyer Beware ...
In his second "Executive Decision" segment of Mad Money Wednesday night, Jim Cramer sat down with Dr. Mike Perry, CEO of Avita Medical , a company pioneering new treatments for burn and wound care. Avita's treatment uses significantly less donor skin to create a spray that can be applied to wide areas of the body. Not only is Avita's treatment less painful, Perry said, it's also less costly and provides a better outcome aesthetically.
If you're interested in Avita Medical Limited (ASX:AVH), then you might want to consider its beta (a measure of share...